Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-020163

EVP, North America Commercial sold 1,179 shares at $16.63 ($19,601)

  • EVP, North America Commercial acquired 1,179 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Grady Brendan P. · EVP, North America Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-17 Exercise or conversion : show line 1 in the form +1,179 2,567.49 D
2019-03-18 Sale : show line 2 in the form −1,179 $16.63 $19,601 1,388.49 D
Open-market sales · 1,179 sh · avg $16.63 · $19,601

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-17 Exercise or conversion : show line 3 in the form Restricted Share Units −1,179 1,179 D
Loading xslF345X03/doc4.xml…